SM-20220

N/A

Report date: 2022/07/01 15:29:28
NME

Base Information

Drug NameSM-20220
Drug Alias NameSM-20220
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSodium-hydrogen exchangers inhibitors
TargetsSodium-hydrogen exchangers
Therapy Area/IndicationsCerebrovascular Disorders
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesSumitomo Chemical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSumitomo Chemical Co Ltd
Active IndicationsN/A
Inactive IndicationsCerebrovascular Disorders

Other Information

ATC CodeN/A
Related LinksN/A